PMID- 10623558 OWN - NLM STAT- MEDLINE DCOM- 20000207 LR - 20031114 IS - 0882-4010 (Print) IS - 0882-4010 (Linking) VI - 28 IP - 1 DP - 2000 Jan TI - Monoclonal anti-LPS inner core antibodies protect against experimental hematogenous Haemophilus influenzae type b meningitis. PG - 1-8 AB - This study tested the protective activity of antibodies to the LPS core of Haemophilus influenzae (Borrelli et al., Infect. Immun. 1995;63: 3683-92) in a hematogenous meningitis model. Meningitis was established by intraperitoneal inoculation of infant rats with H. influenzae type b (Hib). The severity of infection was determined by daily assessment of mortality, symptoms of disease and weight changes. Mortality occurred rapidly after infection with 10(5)cfu/rat and most animals died within 24 h. At a lower infection dose (10(4)cfu/rat) the rats survived, but developed symptoms of disease such as tremor, hypothermia, lethargy and anorexia within 12-72 h post challenge. Surviving animals showed decreased weight gain. Bacteremia was detected by daily blood-cultures in 10/10 rats and cleared 6 days after inoculation. The monoclonal anti-LPS antibody MAHI 3 was used in passive protection studies. MAHI 3 increased the survival in the high inoculum group (10(5)cfu/rat) from 10-17% in control animals to 60-90%. At the lower inoculum concentration (10(4)cfu/rat) MAHI 3 treatment reduced the symptoms and blood counts. Intraperitoneal injection of MAHI 3 was more effective than intranasal injection as shown by the effect on bacteremia. We conclude that anti-LPS antibodies can protect against mortality caused by hematogenous Hib infections in infant rats. CI - Copyright 2000 Academic Press. FAU - Borrelli, S AU - Borrelli S AD - Divisions of Clinical & Oral Bacteriology, Karolinska Institute, Huddinge, 86, S-141, Sweden. FAU - Diab, A AU - Diab A FAU - Lindberg, A AU - Lindberg A FAU - Svanborg, C AU - Svanborg C LA - eng PT - Journal Article PL - England TA - Microb Pathog JT - Microbial pathogenesis JID - 8606191 RN - 0 (Antibodies, Monoclonal) RN - 0 (Lipopolysaccharides) SB - IM MH - Animals MH - Antibodies, Monoclonal/*therapeutic use MH - Bacteremia/prevention & control MH - Haemophilus influenzae/*immunology MH - Lipopolysaccharides/*immunology MH - Meningitis, Haemophilus/*prevention & control MH - Mice MH - Mice, Inbred BALB C MH - Rats MH - Rats, Sprague-Dawley MH - Weight Gain EDAT- 2000/01/07 00:00 MHDA- 2000/01/07 00:01 CRDT- 2000/01/07 00:00 PHST- 2000/01/07 00:00 [pubmed] PHST- 2000/01/07 00:01 [medline] PHST- 2000/01/07 00:00 [entrez] AID - S0882-4010(99)90318-2 [pii] AID - 10.1006/mpat.1999.0318 [doi] PST - ppublish SO - Microb Pathog. 2000 Jan;28(1):1-8. doi: 10.1006/mpat.1999.0318.